Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Nanoparticles are the future of medicine – researchers are experimenting with new ways to design tiny particle treatments for cancer
Duxin Sun, University of Michigan When you hear the word “nanomedicine,” it might call to…
New study identifies genetic changes in patients who progress to oesophageal cancer
More and more mutations clutter up our DNA as we age. Mostly, these don’t cause…
Gene mutations that contribute to head and neck cancer also provide “precision” treatment targets
About one-fifth of often deadly head and neck cancers harbour genetic mutations in a pathway…
Stop worrying and trust the evidence: it’s very unlikely Roundup causes cancer
Ian Musgrave, University of Adelaide The common weed killer Roundup (glyphosate) is back in the news after a US court…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.